DOT1L and neoplasm: In any case, further studies of KMT2A/MLL1, DOT1L and STAT3 dependency across a range of ETS-driven mouse and human tumor models are warranted, particularly with the potential for near-term translational impact using existing clinical-grade inhibitors.